{"id":70573,"sourceType":"sec_filing","title":"SEC EDGAR: 10-K — Monte Rosa Therapeutics, Inc. (2026-03-17)","url":"https://www.sec.gov/Archives/edgar/data/1826457/000119312526109360/0001193125-26-109360-index.htm","publication":"SEC EDGAR","date":"2026-03-17","entity":{"id":2299,"name":"Glue","slug":"glue"},"custody":{"contentHash":"ce8f01fea3ab35ccac612927e425dfe6a88b94f3043a6734661384840f43eb30","contentHashAt":"2026-09-27T19:24:03.127Z","contentLength":588,"capturedAt":"2026-09-27T19:24:03.127Z","hashAlgorithm":"sha256","hashFormula":"sha256(coalesce(url, '<no-url>') || '\\n' || raw_content)","hashEncoding":"hex"},"mediaCitation":null,"preview":"{\n  \"ciks\": [\n    \"0001826457\"\n  ],\n  \"period_ending\": \"2025-12-31\",\n  \"file_num\": [\n    \"001-40522\"\n  ],\n  \"display_names\": [\n    \"Monte Rosa Therapeutics, Inc.  (GLUE)  (CIK 0001826457)\"\n  ],\n  \"xsl\": null,\n  \"sequence\": \"5\",\n  \"root_forms\": [\n    \"10-K\"\n  ],\n  \"file_date\": \"2026-03-17\",\n  \"biz_states\": [\n    \"MA\"\n  ],\n  \"sics\": [\n    \"2836\"\n  ],\n  \"form\": \"10-K\",\n  \"adsh\": \"0001193125-26-109360\",\n  \"film_num\": [\n    \"26759072\"\n  ],\n  \"biz_locations\": [\n    \"Boston, MA\"\n  ],\n  \"file_type\": \"EX-21.1\",\n  \"file_description\": \"EX-21.1\",\n  \"inc_states\": [\n    \"DE\"\n  ],\n  \"items\": []\n}","verifyUrl":"/source/70573/verify","htmlReceiptUrl":"/source/70573/receipt","corpusAttestationUrl":"/attestation/latest.json"}